methoxsalen has been researched along with Skin Diseases in 50 studies
Methoxsalen: A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.
methoxsalen : A member of the class of psoralens that is 7H-furo[3,2-g]chromen-7-one in which the 9 position is substituted by a methoxy group. It is a constituent of the fruits of Ammi majus. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered topically or orally in conjunction with UV-A for phototherapy treatment of vitiligo and severe psoriasis.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
Excerpt | Relevance | Reference |
---|---|---|
"Photochemotherapy using methoxsalen in combination with long-wave ultraviolet light (PUVA) is an essential modality in the treatment of various skin diseases." | 4.80 | PUVA therapy: current concerns in Japan. ( Danno, K, 1999) |
"To understand the photobiological effects and to increase the safety and effectiveness of this novel topical PUVA therapy, we assessed the kinetics and dose-response of phototoxicity of 8-methoxypsoralen (8-MOP) cream in order to develop a treatment schedule for this treatment option." | 2.70 | Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations. ( Grundmann-Kollmann, M; Kaufmann, R; Ludwig, R; Ochsendorf, FR; Podda, M; Tegeder, I; Zollner, TM, 2001) |
"Three phototherapeutic regimens with photosensitization are now used in dermatology: PUVA (psoralen + UVA), TUV (crude coaltar + UV), PRT (phototherapy with hematoporphyrin derivative)." | 2.37 | [Problems posed by the therapeutic use of photosensitizers in dermatology]. ( Amblard, P; Beani, JC; Reymond, JL, 1986) |
"Methoxsalen (8-MOP) may cause important pharmacokinetic drug interactions as it has been shown to inhibit and/or induce several drug-metabolizing enzymes in vitro, in animal models and in humans." | 1.31 | Liver cytochrome P450 CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients. ( Fuhr, U; Scharffetter-Kochanek, K; Servera-Llaneras, M; Tantcheva-Poór, I, 2001) |
"A 23-year-old man with Langerhans cell histiocytosis presented with asymptomatic, purplish, slightly scaly, confluent papules of one year's duration." | 1.30 | Primary cutaneous Langerhans cell histiocytosis treated with photochemotherapy. ( Cho, KH; Kwon, OS; Song, KY, 1997) |
" In one patient who showed a lower absorption rate of 8-MOP plasma levels varied from 0-126 ng/ml." | 1.26 | Intraindividual variations of 8-methoxypsoralen plasma levels. ( Korting, HC; Schäfer-Korting, M, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (60.00) | 18.7374 |
1990's | 12 (24.00) | 18.2507 |
2000's | 5 (10.00) | 29.6817 |
2010's | 3 (6.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rodighiero, P | 1 |
Guiotto, A | 1 |
Chilin, A | 1 |
Bordin, F | 1 |
Baccichetti, F | 1 |
Carlassare, F | 1 |
Vedaldi, D | 2 |
Caffieri, S | 2 |
Pozzan, A | 1 |
Dall'Acqua, F | 2 |
Guillon, CD | 1 |
Jan, YH | 1 |
Foster, N | 1 |
Ressner, J | 1 |
Heck, DE | 1 |
Laskin, JD | 1 |
Heindel, ND | 1 |
Olisova, OY | 1 |
Grabovskaya, OV | 1 |
Teplyuk, NP | 1 |
Tertychnyy, AS | 1 |
Varshavsky, VA | 1 |
Grekova, EV | 1 |
Mok, ZR | 1 |
Tan, ES | 1 |
Chong, WS | 1 |
TOLMAN, MM | 1 |
WILGRAM, GF | 1 |
Pozo-Román, T | 1 |
González-López, A | 1 |
Velasco-Vaquero, ME | 1 |
Núñez-Cabezón, M | 1 |
Jansén, CT | 1 |
Wilén, G | 1 |
Paul, R | 1 |
Westphal, HJ | 1 |
Gschnait, F | 1 |
Wolff, K | 1 |
Hönigsmann, H | 3 |
Stingl, G | 1 |
Brenner, W | 1 |
Jaschke, E | 1 |
Konrad, K | 1 |
Schäfer-Korting, M | 1 |
Korting, HC | 1 |
Garde, E | 1 |
Micic, S | 1 |
Knudsen, K | 1 |
Angelo, HR | 1 |
Wulf, HC | 1 |
Nivsarkar, M | 1 |
Kumar, GP | 1 |
Laloraya, M | 1 |
Knobler, RM | 2 |
Trautinger, F | 1 |
Graninger, W | 1 |
Macheiner, W | 1 |
Gruenwald, C | 1 |
Neumann, R | 1 |
Ramer, W | 1 |
Kwon, OS | 1 |
Cho, KH | 1 |
Song, KY | 1 |
Danno, K | 1 |
Shephard, SE | 1 |
Panizzon, RG | 1 |
Greinix, HT | 1 |
Volc-Platzer, B | 1 |
Kalhs, P | 1 |
Fischer, G | 1 |
Rosenmayr, A | 1 |
Keil, F | 1 |
Grundmann-Kollmann, M | 1 |
Tegeder, I | 1 |
Ochsendorf, FR | 1 |
Zollner, TM | 1 |
Ludwig, R | 1 |
Kaufmann, R | 1 |
Podda, M | 1 |
Tantcheva-Poór, I | 1 |
Servera-Llaneras, M | 1 |
Scharffetter-Kochanek, K | 1 |
Fuhr, U | 1 |
Schiener, R | 1 |
Behrens-Williams, SC | 1 |
Pillekamp, H | 1 |
Peter, RU | 1 |
Kerscher, M | 1 |
Denk, R | 1 |
Oberste-Lehn, H | 1 |
Mortazawi, SA | 1 |
Greaves, MW | 1 |
Weber, G | 2 |
Briffa, DV | 1 |
Warin, AP | 2 |
Cox, AJ | 2 |
Abel, EA | 1 |
Burger, PM | 1 |
Simons, JW | 1 |
Dorval, JC | 1 |
Leroy, JP | 1 |
Massé, R | 1 |
Greene, I | 1 |
Wiskemann, A | 1 |
Poyzer, K | 1 |
Lobel, E | 1 |
King, R | 1 |
Le Guay, J | 1 |
Paver, K | 1 |
Brückner, V | 1 |
Vella Briffa, D | 1 |
Hofmann, C | 2 |
Plewig, G | 2 |
Braun-Falco, O | 2 |
Nath, G | 1 |
Kreitmair, A | 1 |
Lowe, NJ | 1 |
Bures, F | 1 |
Rau, RC | 1 |
Flowers, FP | 1 |
Barrett, JL | 1 |
Stáva, Z | 1 |
Zala, L | 1 |
Omar, A | 1 |
Krebs, A | 1 |
Anders, A | 1 |
Lamprecht, I | 1 |
Schaefer, H | 1 |
Zacharias, H | 1 |
Sinclair, R | 1 |
Roelandts, R | 1 |
Marrakchi, S | 1 |
Decloquement, L | 1 |
Pollet, P | 1 |
Briand, G | 1 |
Loesche, C | 1 |
Bocquet, JL | 1 |
Degand, P | 1 |
Thomas, P | 1 |
Eppinger, T | 1 |
Ehninger, G | 2 |
Steinert, M | 2 |
Niethammer, D | 1 |
Dopfer, R | 2 |
Young, AR | 1 |
Jaschonek, K | 1 |
Einsele, H | 1 |
Schmidt, H | 1 |
Lenz, HJ | 1 |
Beani, JC | 1 |
Amblard, P | 1 |
Reymond, JL | 1 |
Andreassi, L | 1 |
Bovalini, L | 1 |
Martelli, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Single Arm Study of Extracorporeal Photoimmune Therapy With Uvadex For Corticosteroid Sparing in Patients With Corticosteroid-Dependent Crohn's Disease Who May Also Be Refractory or Intolerant to Immunosuppressants and/or Anti-Tumor Necrosis Factor Agen[NCT00056355] | Phase 1 | 10 participants | Interventional | 2003-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for methoxsalen and Skin Diseases
Article | Year |
---|---|
PUVA therapy: current concerns in Japan.
Topics: Humans; Japan; Methoxsalen; Photosensitizing Agents; PUVA Therapy; Skin Diseases; Skin Neoplasms | 1999 |
Dermatology.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Humans; Methoxsalen; Psoriasis; Rosacea; Skin Diseases; Skin D | 1976 |
Photochemotherapy in psoriasis: a review.
Topics: Animals; Cataract; Humans; Methoxsalen; Mutagens; Photochemotherapy; Psoriasis; Rats; Skin Diseases; | 1979 |
[Problems posed by the therapeutic use of photosensitizers in dermatology].
Topics: 5-Methoxypsoralen; Coal Tar; DNA; Furocoumarins; Hematoporphyrin Derivative; Hematoporphyrin Photora | 1986 |
Psoralen photochemotherapy--mechanisms, drugs, toxicity.
Topics: DNA; Erythema; Furocoumarins; Humans; Methoxsalen; Neoplasms, Radiation-Induced; Photosensitivity Di | 1986 |
1 trial available for methoxsalen and Skin Diseases
Article | Year |
---|---|
Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Topics: Administration, Cutaneous; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedu | 2001 |
44 other studies available for methoxsalen and Skin Diseases
Article | Year |
---|---|
Angular furoquinolinones, psoralen analogs: novel antiproliferative agents for skin diseases. Synthesis, biological activity, mechanism of action, and computer-aided studies.
Topics: DNA; Furocoumarins; Mutagens; Myoviridae; Photochemotherapy; RNA; Skin Diseases | 1996 |
Synthetically modified methoxsalen for enhanced cytotoxicity in light and dark reactions.
Topics: Cell Survival; Cells, Cultured; Darkness; Humans; Keratinocytes; Light; Methoxsalen; Photosensitizin | 2019 |
Cutaneous pseudolymphoma caused by Poly Implant Prothèse breast implants.
Topics: Adult; Breast Implants; Female; Humans; Methoxsalen; Photochemotherapy; Pseudolymphoma; Silicone Gel | 2018 |
Treatment of cutaneous plasmacytosis with mask-bath PUVA: A therapeutic option.
Topics: Adult; Baths; Chronic Disease; Humans; Hypergammaglobulinemia; Male; Methoxsalen; Photosensitizing A | 2017 |
Advances in the treatment of skin diseases.
Topics: Adrenal Cortex Hormones; Aminopterin; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antin | 1962 |
Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
Topics: Administration, Cutaneous; Adult; Aged; Chemistry, Pharmaceutical; Female; Humans; Male; Methoxsalen | 2006 |
Variations in skin photosensitization during repeated oral 8-methoxypsoralen medication.
Topics: Administration, Oral; Adult; Female; Humans; Male; Methoxsalen; Middle Aged; Photochemotherapy; PUVA | 1983 |
[Local PUVA therapy with a modified 8-methoxypsoralen solution].
Topics: Dimethyl Sulfoxide; Drug Therapy, Combination; Humans; Methoxsalen; Photochemotherapy; PUVA Therapy; | 1984 |
Long-term photochemotherapy: histopathological and immunofluorescence observations in 243 patients.
Topics: Adult; Antibodies, Antinuclear; Fluorescent Antibody Technique; Humans; Methoxsalen; Middle Aged; Ph | 1980 |
Intraindividual variations of 8-methoxypsoralen plasma levels.
Topics: Adult; Aged; Biological Availability; Female; Humans; Intestinal Absorption; Liver; Male; Metabolic | 1982 |
8-methoxypsoralen increases daytime plasma melatonin levels in humans through inhibition of metabolism.
Topics: Adult; Animals; Antimetabolites; Female; Humans; Male; Melatonin; Methoxsalen; Middle Aged; PUVA The | 1994 |
Photophysical alterations of erythrocyte membrane by 4,5',8-trimethyl psoralen: membrane response towards psoralen phototherapy.
Topics: Animals; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Ethylmaleimide | 1994 |
Parenteral administration of 8-methoxypsoralen in photopheresis.
Topics: Administration, Oral; Capsules; Cell Survival; Chromatography, High Pressure Liquid; Humans; Infusio | 1993 |
Primary cutaneous Langerhans cell histiocytosis treated with photochemotherapy.
Topics: Administration, Oral; Adult; Epidermis; Follow-Up Studies; Histiocytes; Histiocytosis, Langerhans-Ce | 1997 |
Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Topics: 5-Methoxypsoralen; Administration, Oral; Administration, Topical; Baths; DNA Adducts; Female; Humans | 1999 |
Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.
Topics: Acute Disease; Adult; Biopsy; Drug Resistance; Female; Gastrointestinal Hemorrhage; Graft vs Host Di | 2000 |
Liver cytochrome P450 CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Baths; Caffeine; Cytochrome P-450 CYP1 | 2001 |
Does the minimal phototoxic dose after 8-methoxypsoralen baths correlate with the individual's skin phototype?
Topics: Data Interpretation, Statistical; Ficusin; Humans; Methoxsalen; Photochemotherapy; Skin Diseases; St | 2001 |
[Inclusion of clinical-dermatological therapy into general practice? (author's transl)].
Topics: Family Practice; Humans; Keratosis; Methotrexate; Methoxsalen; Patient Care Team; Photochemotherapy; | 1979 |
[Therapeutic results of 8-methoxypsoralen (8-MOP) and UVR (ultraviolet rays)].
Topics: Acne Vulgaris; Adult; Aged; Eczema; Female; Humans; Male; Methoxsalen; Psoriasis; Skin Diseases; Ult | 1975 |
[Utilisation of photochemotherapy by UVA and locally applied psoralens (author's transl)].
Topics: Acne Vulgaris; Eczema; Humans; Methoxsalen; Mycosis Fungoides; Photochemotherapy; Psoriasis; Skin Di | 1977 |
Epidermal dystrophy. Occurrence after psoriasis therapy with psoralen and long-wave ultraviolet light.
Topics: Epidermis; Humans; Methoxsalen; Photochemotherapy; Psoriasis; Skin; Skin Diseases | 1979 |
Mutagenicity of 8-methoxypsoralen and long-wave ultraviolet irradiation in V-79 Chinese hamster cells. A first approach to a risk estimate in photochemotherapy.
Topics: Animals; Cell Line; Cricetinae; Methoxsalen; Mutagens; Photochemotherapy; Risk; Skin Diseases; Ultra | 1979 |
[Disseminated granuloma annulare following puvatherapy].
Topics: Aged; Granuloma; Humans; Male; Methoxsalen; Photochemotherapy; Psoriasis; Skin Diseases | 1979 |
Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light.
Topics: Amyloidosis; Humans; Methoxsalen; Photochemotherapy; Psoriasis; Skin; Skin Diseases | 1979 |
[Adverse effects in the treatment of psoriasis].
Topics: Atrophy; Humans; Methoxsalen; Photochemotherapy; Psoriasis; Skin Diseases; Ultraviolet Therapy | 1979 |
Australian experience with PUVA.
Topics: Humans; Methoxsalen; Photochemotherapy; Skin Diseases | 1979 |
Photosensitizers and radiosensitizers in dermatology and oncology.
Topics: Brain Neoplasms; DNA; Humans; Methoxsalen; Metronidazole; Misonidazole; Mycosis Fungoides; Photochem | 1979 |
Photo-onycholysis caused by photochemotherapy.
Topics: Humans; Methoxsalen; Nails; Skin Diseases; Ultraviolet Therapy | 1977 |
[Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis].
Topics: Adult; Female; Humans; Hypertrichosis; Light; Male; Methoxsalen; Middle Aged; Nails; Photochemothera | 1977 |
A new apparatus for the delivery of high intensity UVA and UVA+UVB irradiation, and some dermatological applications.
Topics: Acrodermatitis; Adult; Aged; Erythema; Erythropoiesis; Female; Humans; Male; Methoxsalen; Photochemo | 1978 |
Woronoff's rings with PUVA therapy.
Topics: Humans; Methoxsalen; Photochemotherapy; Psoriasis; Skin Diseases; Ultraviolet Therapy | 1978 |
Photo-onycholysis secondary to psoralen use.
Topics: Adult; Female; Humans; Methoxsalen; Nails; Photosensitivity Disorders; Skin Diseases | 1978 |
[XV. International Dermatological Congress in Mexico 1977: I. Oral photochemotherapy with the use of methoxsalen].
Topics: Administration, Oral; Humans; Methoxsalen; Photochemotherapy; Skin Diseases | 1978 |
Photo-onycholysis induced by 8-methoxypsoralen.
Topics: Administration, Oral; Adult; Cytoplasmic Granules; Epithelial Cells; Epithelium; Female; Fibroblasts | 1977 |
The use of dye lasers for spectroscopic investigations and photodynamic therapy of human skin.
Topics: Humans; Laser Therapy; Lasers; Methoxsalen; Phototherapy; Pyronine; Skin; Skin Diseases; Spectrophot | 1976 |
Proceedings: Effects and side-effects of 8-methoxypsoralen-blacklight-therapy in more than 1500 patients.
Topics: Humans; Methoxsalen; Psoriasis; Skin Diseases; Ultraviolet Therapy | 1976 |
A review of the 1992 annual meeting of the British Society for Investigative Dermatology.
Topics: Genes, p53; Humans; Methoxsalen; Photochemotherapy; Psoriasis; Skin Diseases; Vitiligo | 1992 |
The history of photochemotherapy.
Topics: History, 20th Century; History, Medieval; Humans; Methoxsalen; Photochemotherapy; Psoriasis; Skin Di | 1991 |
Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Methoxsalen; Middle Aged; PUVA Therapy; Skin Diseases | 1991 |
8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Female; Graft vs Host Disease; Humans; Male; | 1990 |
To tan or not to tan.
Topics: 5-Methoxypsoralen; Animals; Humans; Methoxsalen; Mice; Mice, Hairless; Skin Diseases; Sunscreening A | 1990 |
8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.
Topics: Graft vs Host Disease; Humans; Methoxsalen; PUVA Therapy; Skin Diseases | 1988 |
Khellin, a naturally occurring furochromone, used for the photochemotherapy of skin diseases: mechanism of action.
Topics: Animals; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Cross-Linking Reagents; Dialysis; | 1988 |